This product is a recombinant antibody that recognizes Human CD38. The monoclonal antibody OKT10 reacts with the epitope of CD38.
Figure 1 Pre-incubation of Nalm-6 cells with blocking (SUN-4B7) and nonblocking (OKT10) anti-CD38 mAbs and anti-CXCR4 mAbs differently interferes with homing to spleen and BM.
Cumulative data from at least six animals per condition (a). Total number of human cells (CD19+) out of 105 events is shown. (b) Homing of freshly purified PBMCs from CLL patients was studied using the same model. Data were analyzed by morphological gating on lymphocytes (R1) and subsequently on the CD45+ subset (R2). The CD19/CD5 fluorescence levels were then determined for cells contained in R3 (R1 × R2). (c) Pre-incubation with blocking anti-CD38 mAb (SUN-4B7) negatively interferes with homing of CLL lymphocytes to spleen and BM. Anti-CXCR4 mAb was used as the positive control, whereas an isotype-matched (IgG1) anti-CD38 mAb (OKT10) was used as a binding but nonblocking control mAb. Results are presented as mean±s.e.m. of eight independent experiments, with each condition analyzed in duplicate.
Vaisitti, T., Aydin, S., Rossi, D., Cottino, F., Bergui, L., D'arena, G., ... & Gaidano, G. (2010). CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia, 24(5), 958.
Figure 2 Binding of anti-CD38 antibody constructs to CD38 on malignant plasma cells.
Competitive binding assays demonstrate blocking of Alexa-647–conjugated OKT10 mAb binding to CD38-expressing L363 multiple myeloma cells with escalating concentrations of unlabeled OKT10-FP (A) or OKT10-CC (B). No blocking is observed with escalating concentrations of nonbinding control Ab constructs.
Green, D. J., Orgun, N. N., Jones, J. C., Hylarides, M. D., Pagel, J. M., Hamlin, D. K., ... & Frayo, S. L. (2014). A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies. Cancer research, 74(4), 1179-1189.
Figure 3 A detailed organ dosimetry analysis was performed to calculate 90Y absorbed dose estimates after OKT10-CC pretargeting.
90Y absorbed dose estimates (Gy/mCi) from an 111In–DOTA–biotin tracer. Radiation absorbed doses to tumor, whole body, and normal tissues are estimated by integrating the areas under time–activity curves constructed by plotting the concentration of 111In–DOTA–biotin (after OKT10-CC pretargeting) measured in tissues by γ counting at 2, 24, 48, and 96 hours (33).
Green, D. J., Orgun, N. N., Jones, J. C., Hylarides, M. D., Pagel, J. M., Hamlin, D. K., ... & Frayo, S. L. (2014). A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies. Cancer research, 74(4), 1179-1189.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
NABL-079 | Recombinant Anti-Human CD38 VHH Single Domain Antibody | WB, IHC, FC, FuncS | Llama VHH |
HPAB-0625-CN | Recombinant Bactrian camel Anti-CD38 Single Domain Antibody (Nb1) | ELISA | VHH |
HPAB-0626-CN | Recombinant Bactrian camel Anti-CD38 Single Domain Antibody (Nb2) | ELISA | VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-425 | Mouse Anti-CD38 Recombinant Antibody (clone HB7) | WB, ELISA, FuncS | Mouse IgG |
HPAB-0300-YC | Human Anti-CD38 Recombinant Antibody (HPAB-0300-YC) | Cyt | Human IgG |
HPAB-0301-YC | Human Anti-CD38 Recombinant Antibody (HPAB-0301-YC) | ELISA, FC, Cyt | Human IgG1 |
HPAB-0302-YC | Human Anti-CD38 Recombinant Antibody (HPAB-0302-YC) | FuncS | Humanized IgG1 |
HPAB-0402-CN | Human Anti-CD38 Recombinant Antibody (HPAB-0402-CN) | ELISA, FC | Human IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBC-211 | Recombinant Mouse Anti-CD38 Antibody scFv Fragment (HB7) | ELISA | scFv |
HPAB-0402-CN-F(E) | Human Anti-CD38 Recombinant Antibody; Fab Fragment (HPAB-0402-CN-F(E)) | ELISA, FC | Human Fab |
HPAB-1357LY-F(E) | Human Anti-CD38 Recombinant Antibody; Fab Fragment (HPAB-1357LY-F(E)) | ELISA | Human Fab |
HPAB-1358LY-F(E) | Human Anti-CD38 Recombinant Antibody; Fab Fragment (HPAB-1358LY-F(E)) | ELISA | Human Fab |
HPAB-1359LY-F(E) | Human Anti-CD38 Recombinant Antibody; Fab Fragment (HPAB-1359LY-F(E)) | ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-151LC | Mouse Anti-CD38 Recombinant Antibody (TAB-151LC) | ELISA | Mouse IgG, κ |
TAB-151LC-S(P) | Mouse Anti-CD38 Recombinant Antibody; scFv Fragment (TAB-151LC-S(P)) | ELISA | Mouse scFv |
TAB-151LC-F(E) | Mouse Anti-CD38 Recombinant Antibody; Fab Fragment (TAB-151LC-F(E)) | ELISA | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-152LC-S(P) | Human Anti-CD38 Recombinant Antibody; scFv Fragment (TAB-152LC-S(P)) | FC | Human scFv |
TAB-153LC-S(P) | Human Anti-CD38 Recombinant Antibody; scFv Fragment (TAB-153LC-S(P)) | ELISA, FC | Human scFv |
TAB-154LC-S(P) | Human Anti-CD38 Recombinant Antibody; scFv Fragment (TAB-154LC-S(P)) | ELISA, FC | Human scFv |
TAB-155LC-S(P) | Human Anti-CD38 Recombinant Antibody; scFv Fragment (TAB-155LC-S(P)) | ELISA, FC | Human scFv |
TAB-156LC-S(P) | Human Anti-CD38 Recombinant Antibody; scFv Fragment (TAB-156LC-S(P)) | ELISA, FC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-349CQ | Rat Anti-CD38 Recombinant Antibody (clone NIMR-5) | Neut, FC, IHC-Fr, IP, BA | Rat IgG2a, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0556 | Hi-Affi™ Rabbit Anti-CD38 Recombinant Antibody (clone DS556AB) | FC, ICC, IHC-P, WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0046CQ-S(P) | Mouse Anti-CD38 Recombinant Antibody (clone AT13/5); scFv Fragment | ELISA, FC | Mouse scFv |
HPAB-0262-YJ-S(P) | Human Anti-CD38 Recombinant Antibody; scFv Fragment (HPAB-0262-YJ-S(P)) | FuncS | Human scFv |
HPAB-0535-WJ-S(P) | Rat Anti-CD38 Recombinant Antibody; scFv Fragment (HPAB-0535-WJ-S(P)) | ELISA, WB | Rat scFv |
HPAB-0536-WJ-S(P) | Rat Anti-CD38 Recombinant Antibody; scFv Fragment (HPAB-0536-WJ-S(P)) | ELISA, WB | Rat scFv |
HPAB-0537-WJ-S(P) | Rat Anti-CD38 Recombinant Antibody; scFv Fragment (HPAB-0537-WJ-S(P)) | ELISA, WB | Rat scFv |
There are currently no Customer reviews or questions for HPAB-0379-FY. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.